{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:29:25Z","timestamp":1787804965678,"version":"build-2784847793"},"reference-count":59,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV no. 260386"],"award-info":[{"award-number":["SVV no. 260386"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["PROGRES Q34"],"award-info":[{"award-number":["PROGRES Q34"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim of the study was to determine if aberrant expression profile of cardiovascular disease associated microRNAs would be able to predict within 10 to 13 weeks of gestation preterm delivery such as spontaneous preterm birth (PTB) or preterm prelabor rupture of membranes (PPROM) in the absence of other pregnancy-related complications (gestational hypertension, preeclampsia, fetal growth restriction, or small for gestational age). In addition, we assessed if aberrant expression profile of cardiovascular disease associated microRNAs would be able to predict preterm delivery before and after 34 weeks of gestation. The retrospective study was performed within the period November 2012 to March 2020. Whole peripheral blood samples were collected from 6440 Caucasian individuals involving 41 PTB and 65 PPROM singleton pregnancies. A control group, 80 singleton term pregnancies, was selected on the base of equal sample storage time. Gene expression of 29 selected cardiovascular disease associated microRNAs was studied using real-time RT-PCR. Downregulation of miR-16-5p, miR-20b-5p, miR-21-5p, miR-24-3p, miR-26a-5p, miR-92a-3p, miR-126-3p, miR-133a-3p, miR-145-5p, miR-146a-5p, miR-155-5p, miR-210-3p, miR-221-3p and miR-342-3p was observed in pregnancies with preterm delivery before 37 (\u226436 + 6\/7) weeks of gestation. Majority of downregulated microRNAs (miR-16-5p, miR-24-3p, miR-26a-5p, miR-92a-3p, miR-133a-3p, miR-145-5p, miR-146a-5p, miR-155-5p, miR-210-3p, and miR-342-3p) was associated with preterm delivery occurring before 37 (\u226436 + 6\/7) weeks of gestation. The only miR-210-3p was downregulated in pregnancies with preterm delivery before 34 (\u226433 + 6\/7) weeks of gestation. The type of preterm delivery also had impact on microRNA gene expression profile. Downregulation of miR-24-3p, miR-92a-3p, miR-155-5p, and miR-210-3p was a common feature of PTB and PPROM pregnancies. Downregulation of miR-16-5p, miR-20b-5p, miR-26a-5p, miR-126-3p, miR-133a-3p, miR-146a-5p, miR-221-3p, and miR-342-3p appeared just in PTB pregnancies. No microRNA was uniquely dysregulated in PPROM pregnancies. The combination of 12 microRNAs (miR-16-5p, miR-20b-5p, miR-21-5p, miR-24-3p, miR-26a-5p, miR-92a-3p, miR-133a-3p, miR-145-5p, miR-146a-5p, miR-155-5p, miR-210-3p, and miR-342-3p, AUC 0.818, p &lt; 0.001, 74.53% sensitivity, 75.00% specificity, cut off &gt; 0.634) equally as the combination of 6 microRNAs (miR-16-5p, miR-21-5p, miR-24-3p, miR-133a-3p, miR-155-5p, and miR-210-3p, AUC 0.812, p &lt; 0.001, 70.75% sensitivity, 78.75% specificity, cut off &gt; 0.652) can predict preterm delivery before 37 weeks of gestation in early stages of gestation in 52.83% pregnancies at 10.0% FPR. Cardiovascular disease associated microRNAs represent promising biomarkers with very good diagnostical potential to be implemented into the current routine first trimester screening programme to predict preterm delivery.<\/jats:p>","DOI":"10.3390\/ijms23073951","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:22:39Z","timestamp":1648848159000},"page":"3951","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4396-3304","authenticated-orcid":false,"given":"Ilona","family":"Hromadnikova","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kotlabova","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Krofta","sequence":"additional","affiliation":[{"name":"Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, 147 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"ref_2","first-page":"571","article-title":"Preterm prevention: Effectivenss of current strategies","volume":"18","author":"Moutquin","year":"1996","journal-title":"J. Soc. Obstet. Gynaecol. Can."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., and Krofta, L. (2021). A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084033"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","article-title":"Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women","volume":"135","author":"Tanz","year":"2017","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/jwh.2013.4248","article-title":"Prior preterm birth and maternal subclinical cardiovascular disease 4 to 12 years after pregnancy","volume":"22","author":"Catov","year":"2013","journal-title":"J. Womens Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.111.00143","article-title":"Preterm birth and future maternal blood pressure, inflam-mation, and intimal-medial thickness: The CARDIA study","volume":"61","author":"Catov","year":"2013","journal-title":"Hypertension"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.annepidem.2014.10.012","article-title":"Preterm birth and long-term maternal car-diovascular health","volume":"25","author":"Perng","year":"2015","journal-title":"Ann. Epidemiol."},{"key":"ref_9","first-page":"347","article-title":"Effect of premature birth on long-term systolic blood pressure variability in women","volume":"20","author":"Shi","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e013092","DOI":"10.1161\/JAHA.119.013092","article-title":"NHLBI nuMoM2b Heart Health Study. Association of Adverse Pregnancy Outcomes with Hypertension 2 to 7 Years Postpartum","volume":"8","author":"Haas","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/jwh.2018.7150","article-title":"Preterm Delivery and Maternal Cardiovascular Disease Risk Factors: The Nurses\u2019 Health Study II","volume":"28","author":"Tanz","year":"2019","journal-title":"J. Womens Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/HYPERTENSIONAHA.117.10693","article-title":"Blood Pressure Patterns and Subsequent Coronary Artery Calcification in Women Who Delivered Preterm Births","volume":"72","author":"Catov","year":"2018","journal-title":"Hypertension"},{"key":"ref_13","first-page":"E156","article-title":"Gestational age, infant birth weight, and subsequent risk of type 2 diabetes in mothers: Nurses\u2019 Health Study II","volume":"10","author":"Karumanchi","year":"2013","journal-title":"Prev. Chronic Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1471-0528.2009.02448.x","article-title":"Preterm delivery and risk of subsequent cardiovascular morbidity and type-II diabetes in the mother","volume":"117","author":"Lykke","year":"2010","journal-title":"BJOG"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0000000000000167","article-title":"Preterm birth and subsequent risk of type 2 diabetes in black women","volume":"25","author":"Wise","year":"2014","journal-title":"Epidemiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/jwh.2018.7148","article-title":"Women with Preterm Birth Have Evidence of Subclinical Atherosclerosis a Decade after Delivery","volume":"28","author":"Catov","year":"2019","journal-title":"J. Womens Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1161\/CIRCULATIONAHA.111.034884","article-title":"Birth characteristics and subsequent risks of maternal cardiovascular disease: Effects of gestational age and fetal growth","volume":"124","author":"Bonamy","year":"2011","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ngo, A.D., Chen, J.S., Figtree, G., Morris, J.M., and Roberts, C.L. (2015). Preterm birth and future risk of maternal cardiovascular disease\u2014Is the association independent of smoking during pregnancy?. BMC Pregnancy Childbirth, 15.","DOI":"10.1186\/s12884-015-0571-7"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.hjr.0000183917.35978.a6","article-title":"Preterm delivery of a first child and subsequent mothers\u2019 risk of ischaemic heart disease: A nested case-control study","volume":"13","author":"Nardi","year":"2006","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2020.04.072","article-title":"Pre-Term Delivery and Risk of Is-chemic Heart Disease in Women","volume":"76","author":"Crump","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.annepidem.2010.05.007","article-title":"Early or recurrent preterm birth and maternal cardio-vascular disease risk","volume":"20","author":"Catov","year":"2010","journal-title":"Ann. Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-3016.2010.01120.x","article-title":"Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery","volume":"24","author":"Lykke","year":"2010","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"ref_24","first-page":"e1","article-title":"Duration of pregnancy, even at term, predicts long-term risk of coronary heart disease and stroke mortality in women: A population-based study","volume":"213","author":"Klungsoyr","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"m2533","DOI":"10.1136\/bmj.m2533","article-title":"Preterm delivery and long term mortality in women: National cohort and co-sibling study","volume":"370","author":"Crump","year":"2020","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ije\/dyq270","article-title":"Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: Retrospective cohort study of 750 350 singleton pregnancies","volume":"40","author":"Hastie","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e007809","DOI":"10.1161\/JAHA.117.007809","article-title":"Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"7","author":"Wu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Winger, E.E., Reed, J.L., and Ji, X. (2017). Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: Proof of concept. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180124"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Winger, E.E., Reed, J.L., Ji, X., Gomez-Lopez, N., Pacora, P., and Romero, R. (2020). MicroRNAs isolated from peripheral blood in the first trimester predict spontaneous preterm birth. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236805"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pd.2662","article-title":"Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11\u201313 weeks","volume":"31","author":"Beta","year":"2011","journal-title":"Prenat. Diagn."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: Comparison with NI-CE guidelines and ACOG recommendations","volume":"49","author":"Wright","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_32","first-page":"e1","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"Wright","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","unstructured":"The Fetal Medicine Foundation (2022, January 06). Stratification of Pregnancy Management 11\u201313 Weeks\u2019 Gestation. Available online: www.courses.fetalmedicine.com\/fmf\/show\/861?locale=en."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.22093","article-title":"Screening for pre-eclampsia at 11\u201313 weeks\u2019 gestation: Use of pregnancy-associated plasma protein-A, placental growth factor or both","volume":"56","author":"Wright","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fimmu.2018.00993","article-title":"Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the Role of Adaptive and Innate Immunity in Preterm Birth","volume":"9","author":"Vora","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/biomedicines10020256","article-title":"Cardiovascular-Disease Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction","volume":"10","author":"Hromadnikova","year":"2022","journal-title":"Biomedicines"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., and Krofta, L. (2022). First Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia using Cardiovascular-Disease Associated MicroRNA Biomarkers. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030718"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0002-9378(95)91377-7","article-title":"Risk factors for the development of pre-term premature rupture of the membranes after arrest of preterm labor","volume":"173","author":"Guinn","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1933719108329095","article-title":"Inflammation and pregnancy","volume":"16","author":"Challis","year":"2009","journal-title":"Reprod. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jri.2010.11.003","article-title":"Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth","volume":"88","author":"Keelan","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ije\/22.3.495","article-title":"Risks for premature rupture of amniotic membranes","volume":"22","author":"Ekwo","year":"1993","journal-title":"Int. J. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-2007-999527","article-title":"Risk factors for preterm premature rupture of the fetal membranes","volume":"7","author":"Hadley","year":"1990","journal-title":"Am. J. Perinatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(80)90674-1","article-title":"Causes and consequences of premature rupture of fetal membranes","volume":"1","author":"Naeye","year":"1980","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ajpath.2014.02.011","article-title":"Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro","volume":"184","author":"Menon","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/aji.12220","article-title":"Expression of 8-oxoguanine glycosylase in human fetal membranes","volume":"72","author":"Menon","year":"2014","journal-title":"Am. J. Reprod. Immunol"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Menon, R., Yu, J., Basanta-Henry, P., Brou, L., Berga, S.L., Fortunato, S.J., and Taylor, R.N. (2013). Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031136"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E836","DOI":"10.1152\/ajpendo.00660.2012","article-title":"Differential miRNA expression profiles between the first and third trimester human placentas","volume":"304","author":"Gu","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.toxrep.2020.08.002","article-title":"Placental microRNAs: Responders to environmental chemicals and mediators of pathophysiology of the human placenta","volume":"7","author":"Addo","year":"2020","journal-title":"Toxicol. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Committee on Obstetric Practice, and Society for Maternal-Fetal Medicine (2018). ACOG Committee Opinion No. 743. Low-Dose Aspirin Use during Pregnancy. Obstet. Gynecol., 132, e44\u2013e52.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"ref_51","unstructured":"National Institute for Health and Care Excellence (2022, January 06). Hypertension in Pregnancy: Diagnosis and Management. Available online: www.nice.org.uk\/guidance\/ng133."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., and Krofta, L. (2021). Association Analysis in Young and Middle-Aged Mothers-Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings. J. Pers. Med., 11.","DOI":"10.3390\/jpm11010039"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2015.11.032","article-title":"Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood","volume":"137","author":"Hromadnikova","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., Hympanova, L., and Krofta, L. (2015). Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138383"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","article-title":"miRWalk\u2014Database: Prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes","volume":"44","author":"Dweep","year":"2011","journal-title":"J. Biomed. Inform."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3951\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:48:44Z","timestamp":1760136524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073951"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073951","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}